Healthcare Industry News: Benign Prostatic Hyperplasia
News Release - May 18, 2007
American Medical Systems Announces the Introduction of the TherMatrx TMX3000(TM) Office Thermo Therapy System
Therapy Improved to Provide Increased Physician Convenience and Ease of UseMINNEAPOLIS--(HSMN NewsFeed)--American Medical Systems Holdings, Inc. (NASDAQ:AMMD ) announced today that it has received FDA approval for its new TherMatrx TMX3000(TM) thermo therapy system and will immediately launch this innovative in-office treatment of Benign Prostatic Hyperplasia (BPH) into the U.S. market.
More than 9 million men in the United States suffer from BPH (more commonly known as enlarged prostate), a natural and non-cancerous condition where the prostate grows and compromises ordinary urethral function. Common symptoms include frequent urination (especially at night), a sudden need to urinate, and a weak urine stream.
The TherMatrx TMX3000 system, which replaces the TherMatrx TMX2000(TM), offers physicians a non-surgical, in-office treatment solution for their patients with BPH. The new TMX3000 system is both customizable and easy to use, with three different protocol settings, a new touch screen monitor, and automatic calibration of temperature sensors. "The multiple protocol options and the automatic sensor calibration on the new TMX3000 enable me to more flexibly manage the patient scheduling in my practice. I view this as a meaningful advance for in-office treatment of my patients with BPH", said Dr. Kenneth Langer of Chesapeake Urology Associates.
Importantly, the efficacy of the TherMatrx TMX3000 thermo therapy system is supported with five-year data proving improved quality of life for patients. Over 60,000 patients have been treated since 2001 with no long-term side effects or unexpected adverse events reported.
Martin J. Emerson, President and Chief Executive Officer of American Medical Systems, added, "The mission of AMS is to restore lives by improving pelvic health, and the new TherMatrx TMX3000 system is an important and innovative step forward in the in-office treatment of BPH. We are pleased to introduce this proven, efficacious and convenient solution to physicians and their patients."
For more information on the TMX3000, please visit our website at www.thermatrx.com.
About American Medical Systems
American Medical Systems, headquartered in Minnetonka, Minnesota and including its 2006 acquisition of Laserscope, is a diversified supplier of medical devices and procedures to cure erectile dysfunction, Benign Prostatic Hyperplasia, incontinence, menorrhagia, prolapse and other pelvic disorders in men and women. These disorders can significantly diminish one's quality of life and profoundly affect social relationships. In recent years, the number of people seeking treatment has increased markedly as a result of longer lives, higher quality-of-life expectations and greater awareness of new treatment alternatives. American Medical Systems' products reduce or eliminate the incapacitating effects of these diseases, often through minimally invasive therapies. The Company's products were used to treat approximately 240,000 patients in 2006.
More information about the Company and its products can be found at its website www.AmericanMedicalSystems.com and in the Company's Annual Report on Form 10-K for 2006 and its other SEC filings.
Source: American Medical Systems Holdings
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
